semaglutide shortage resolved Novo Nordisk's officially concludes in the US, spelling major threat for weight loss drug compounders 🚨 FDA Ends Semaglutide Shortage

Chapter 8

537 patients with type 2 diabetes (85% treatment-naive) at 40 weeks

While the long-term effects of Ozempic are still being studied, it is important to prioritize your health and make informed decisions

Bacio Lips Get the perfect glow with our Bacio Lips Treatmenta luxurious, non-invasive treatment crafted to hydrate, smooth, and subtly enhance your lips

Clinical Trial Results Clinical trials report weight loss averages around 15-20%

Seek medical advice promptly if you experience : Severe or persistent vomiting : This may lead to dehydration and affect blood glucose control, and could indicate gastroparesis (severe delayed gastric emptying) Severe abdominal pain : Particularly if constant, persistent, or radiating to the back, as GLP-1 receptor agonists carry a small risk of pancreatitis Right upper abdominal pain, fever or jaundice : These may indicate gallbladder problems, which can occur with GLP-1 receptor agonists Signs of dehydration : Including dark urine, dizziness, reduced urination, or extreme thirst Inability to tolerate food or fluids : This affects both nutrition and diabetes management Blood in vomit or stools : This requires immediate medical assessment Symptoms of hypoglycaemia : Particularly if taking Victoza alongside sulfonylureas or insulin For urgent concerns, contact NHS 111 or attend your local A&E department if symptoms are severe